Global Peptide Synthesis Market is estimated to value over USD 430 million by 2026 end and register a CAGR of over 5.5% during the forecast period 2019 to 2026. 

Growing usage of peptides in pharmaceutical drugs, development of advanced peptide synthesizers and availability of funding for research and development activities related to peptides are some key driving factors of the global peptide synthesis market.

However, a lack of unified regulations for peptides used in therapy shall prove to be a major restraining factor for the market growth. 

The Asia Pacific region is a lucrative market space and this could create numerous profitable opportunities for the global peptide synthesis market to grow exponentially. Nonetheless, the issues associated with the administrative route of peptide drugs pose some tough challenges for the peptide synthesis market growth. 

The Usage of Advanced Peptide Synthesizers is Key to the Growth of the Market

Peptides are biologically diverse which is why they are used in extensive therapeutic areas. Furthermore, they are widely utilised as a potential active pharmaceutical ingredient in drug development pathways due to their high specificity, relative ease of synthesis, high biological activity, low toxicity and ready availability. Peptides generate huge sums of money through diabetes, oncology and obesity-the three most prominent therapeutic areas for peptide synthesis. As a drug modality, peptidomimetics and peptides acquire the interface between large biological drugs and small molecules with the capability to have the bioavailability of small molecules and the specificity of antibodies. 

Furthermore, peptides are chemically synthesized or expressed by recombinant systems to provide viable options for researchers for discovering, manufacturing and optimizing peptide-based drugs which are why pharmaceutical companies are prioritizing on developing these drugs. 

Key market players include Genscript Biotech, Merck KGaA, Aapptec, Bachman Holdings, Anapec, Biotage, CEM Corp., Gyros Protein Technologies, Advanced Chemtech, NEP (New England Peptide).

Merck completed the acquisition of Grzybowski Scientific Inventions (GSI) in 2017. This acquisition helped Merck expand its chemical synthesis portfolio. Merck acquired Sigma-Aldrich Corp. in 2015 which strengthened their life science segment. Sigma-Aldrich’s SAFC commercial business is now a part of this segment. CEM Corp. launched the Liberty PRIME in 2018 which is an automated microwave peptide synthesizer.

Biotage is the only company to manufacture microwave peptide synthesizers and room temperature peptide synthesizers in both high throughput and entry-level configurations which shall assist Biotage with the market expansion worldwide. Furthermore, they have a fully automated microwave peptide synthesizer Initiator+ Alstra, which is packed with advanced features like Preactivation, Branches and ‘Edit on the fly’. It also has options for MAOS and UV monitoring capability. This is a best-in-class system for both large and small scale peptide synthesis, PNA, peptidomimetics and peptoids. This shall help them gain significant market traction in the microwave peptide synthesizer segment over the forecast period.

Global Peptide Synthesizers Market Segmentation:

By Product

· Reagents

· Equipment

· Peptide Synthesizers

· Chromatography Equipment

· Lyophilizers

By Technology

· Solid-Phase Peptide Synthesis (SPPS)

· Solution-Phase Synthesis (SPS)

· Hybrid and Recombinant Technology

By End User

· Pharmaceutical and Biotechnology Companies

· Contract Research Organization (CRO)

· Academic and Research Institutes

By Region

· North America

· Europe

· Asia Pacific 

· Latin America

· Middle East & Africa

FutureWise Key Takeaways: 

• Growth prospects

• SWOT analysis 

• Key trends 

• Key data-points affecting market growth 

Objectives of the Study:

· To provide with an exhaustive analysis on the global peptide synthesis market by product, by technology, by end user and by region

· To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

· To evaluate and forecast micro-markets and the overall market 

· To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa

· To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

· Profiling of companies to evaluate their market shares, strategies, financials and core competencies

 

Get unlimited analyst support and customise this study further to your requirements, contact sales@futurewiseresearch.com